rs199608505

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001382391.1(CSPP1):​c.1693G>A​(p.Val565Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00164 in 1,602,522 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00094 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0017 ( 4 hom. )

Consequence

CSPP1
NM_001382391.1 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: -1.42
Variant links:
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046307743).
BP6
Variant 8-67118817-G-A is Benign according to our data. Variant chr8-67118817-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 449196.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00094 (143/152166) while in subpopulation NFE AF= 0.00159 (108/67954). AF 95% confidence interval is 0.00135. There are 0 homozygotes in gnomad4. There are 50 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSPP1NM_001382391.1 linkc.1693G>A p.Val565Ile missense_variant Exon 15 of 31 ENST00000678616.1 NP_001369320.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSPP1ENST00000678616.1 linkc.1693G>A p.Val565Ile missense_variant Exon 15 of 31 NM_001382391.1 ENSP00000504733.1 A0A7I2V5W3

Frequencies

GnomAD3 genomes
AF:
0.000940
AC:
143
AN:
152048
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0121
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00159
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.000938
AC:
233
AN:
248374
Hom.:
0
AF XY:
0.000839
AC XY:
113
AN XY:
134712
show subpopulations
Gnomad AFR exome
AF:
0.000713
Gnomad AMR exome
AF:
0.000669
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000931
Gnomad NFE exome
AF:
0.00172
Gnomad OTH exome
AF:
0.000498
GnomAD4 exome
AF:
0.00172
AC:
2491
AN:
1450356
Hom.:
4
Cov.:
27
AF XY:
0.00158
AC XY:
1144
AN XY:
722278
show subpopulations
Gnomad4 AFR exome
AF:
0.000481
Gnomad4 AMR exome
AF:
0.000627
Gnomad4 ASJ exome
AF:
0.0000769
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000750
Gnomad4 NFE exome
AF:
0.00213
Gnomad4 OTH exome
AF:
0.00163
GnomAD4 genome
AF:
0.000940
AC:
143
AN:
152166
Hom.:
0
Cov.:
32
AF XY:
0.000672
AC XY:
50
AN XY:
74398
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000393
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00159
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.00144
Hom.:
0
Bravo
AF:
0.00107
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000545
AC:
2
ESP6500EA
AF:
0.00135
AC:
11
ExAC
AF:
0.000811
AC:
98
EpiCase
AF:
0.00153
EpiControl
AF:
0.00154

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Oct 25, 2023
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CSPP1: BP4 -

Joubert syndrome 21 Uncertain:1
Oct 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 560 of the CSPP1 protein (p.Val560Ile). This variant is present in population databases (rs199608505, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with CSPP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 449196). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

CSPP1-related disorder Benign:1
Feb 15, 2022
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.0030
DANN
Benign
0.17
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0066
N
LIST_S2
Benign
0.43
T;T
M_CAP
Benign
0.0030
T
MetaRNN
Benign
0.0046
T;T
MetaSVM
Benign
-0.97
T
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.17
N;N
REVEL
Benign
0.017
Sift
Benign
0.81
T;T
Sift4G
Benign
0.32
T;T
Polyphen
0.0
B;B
Vest4
0.11
MVP
0.20
MPC
0.098
ClinPred
0.0042
T
GERP RS
-7.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.075

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199608505; hg19: chr8-68031052; API